- Home
- NEWS
- REGIONAL
- THIS WEEK'S PAPER
- BLOGS
- Multimedia
- OPINION
- A&E
- LISTS
- PEOPLE
- EVENTS
- Classifieds
- Subscribe
Health Care Businesses
Court may decide if drugmakers can pay to delay generics
March 25, 2013
Associated PressFederal regulators are pressing the Supreme Court to stop big pharmaceutical corporations from paying generic drug competitors
to delay releasing their cheaper versions of brand-name drugs. They argue these deals deny American consumers, usually for
years, steep price declines.
MoreFDA probe of diabetes medications hurts drugmakers' stock
March 15, 2013
Bloomberg News, Associated PressShares of several pharmaceutical companies that make diabetes medicines, including Eli Lilly, fell after U.S. regulators warned
they are looking into potential risks of drugs in two classes of diabetes treatments.
MoreDrugmakers, Interpol ramp up fight against fakes
March 12, 2013
Associated PressMore than two dozen of the world's largest pharmaceutical companies, including Indianapolis-based Eli Lilly and Co., have
agreed to provide funding and other support to Interpol's battle against counterfeit prescription drugs.
MoreOverseas tax savings for U.S. drugmakers under threat
March 11, 2013
Bloomberg NewsEli Lilly and Co. and five other big drugmakers avoided paying $7 billion in U.S. taxes last year by shifting their profits
overseas. The strategy has drawn the ire of some legislators.
MoreLilly sues Genentech to invalidate Erbitux-related patents
March 2, 2013
Bloomberg NewsEli Lilly and Co. has sued Roche Holding AG’s Genentech unit, asking a court to invalidate patents used to make treatments
for cancer and autoimmune diseases.
MoreLEADING QUESTIONS: Mainstreet CEO masters efficiency
February 27, 2013
Mason King
What are Zeke Turner's top five strategies for keeping his work week under 40 hours? Do you really need work e-mail
on your smart phone? What's it like to take a company public? The real estate exec has answers.
Endocyte stock sinks due to possible drug-filing delay
February 26, 2013
J.K. WallEndocyte Inc. saw its shares fall nearly 7 percent Tuesday morning after the drug development firm announced that its application
for U.S. approval of a cancer drug could be delayed another 10 months.
MoreTestosterone for diabetes may be new market for Lilly, others
February 25, 2013
Bloomberg NewsResearchers suspect the sex hormone known to increase libido and musculature could also play a role in preventing a form of
diabetes that tends to strike later in life and afflicts more than 330 million people worldwide.
MoreLilly to expand partnership with diagnostic firm
February 14, 2013
IBJ Staff and Associated PressDiagnostic products maker Qiagen NV said Wednesday that it will work with Eli Lilly and Co. to develop new tests that could
identify patients who could be helped by Lilly's drugs.
MoreLilly halts late-stage testing of rheumatoid arthritis drug
February 7, 2013
Bloomberg NewsEli Lilly said it is halting testing of experimental drug tabalumab because the studies show the medicine is not effective.
The company said it expects to take a $50 million charge in the first quarter related to the research expenses from the drug.
MoreLife sciences consultancy plans to expand, add 38 jobs
January 29, 2013
Indianapolis-based Pearl Pathways, founded by two former Eli Lilly employees, plans to move into new space in March and add
the jobs by 2016.
MoreOnce-thriving drug lab in turnaround mode
January 26, 2013
J.K. WallTwo years ago, executives at AIT Laboratories “took their eye off the ball,” and watched the company’s business
plummet 29 percent in value. Now, after two years of turmoil, the drug-testing lab says it’s poised to return to the
double-digit rates of growth that made it a local star.
MoreGreenwood seeks funds back from drugmaker with big plans
January 22, 2013
J.K. WallGreenwood-based Elona Biotechnologies Inc., which has been trying to bring a generic version of insulin to market, was declared
in default on $8.4 million in incentives from the city of Greenwood.
MoreLilly drug chosen for Alzheimer's prevention study
January 18, 2013
Associated PressResearchers have chosen an experimental drug by Eli Lilly and Co. for a large federally funded study testing whether it's
possible to prevent Alzheimer's disease in older people at high risk of developing it.
MoreRoche makes Fortune’s ‘Best Companies’ list
January 18, 2013
Roche Diagnostics Corp. in Indianapolis ranks 89th on the magazine's latest "Best Companies to Work For" list and was the
only Indiana-based company selected.
MoreLilly's Amyvid receives European approval
January 16, 2013
Associated PressEuropean regulators approved the use of an imaging agent from Eli Lilly and Co., which can help doctors diagnose Alzheimer's
disease.
MoreLilly competitor gets backing on diabetes drug
January 10, 2013
Bloomberg NewsJohnson & Johnson, the world’s largest seller of health-care products, won the backing of U.S. advisers for a diabetes pill
the company is seeking to make the first in a new family of drugs for managing blood sugar.
MoreLilly settles with four sisters in DES cancer case
January 9, 2013
Associated PressFour sisters who claimed their breast cancer was caused by a drug their mother took during pregnancy in the 1950s reached
a settlement Wednesday with Eli Lilly and Co. in the first of scores of similar claims around the country to go to trial.
MoreDrug sold by Lilly caused cancer, women claim at Boston trial
January 8, 2013
Associated PressIn opening statements Tuesday, a lawyer for Indianapolis-based Lilly told the jury there is no evidence the synthetic estrogen
known as DES causes breast cancer in the daughters of women who took it.
MoreFiscal cliff deal threatens Indiana co-op health plan
January 7, 2013
J.K. WallLast week’s fiscal cliff bargain in Congress dealt a potentially fatal blow to a new health insurance plan, called Remedy
Indiana, that was set to launch this year.
MoreSpotlight falls on IU Health for flu shot firings
January 7, 2013
J.K. WallIndiana University Health got national attention last week for its decision to dismiss eight employees for refusing to get
a flu vaccination. The Indianapolis-based hospital system fired three nurses and five other employees from its IU Health Goshen
Hospital.
MoreBig drug deals expected to return in 2013
January 7, 2013
Bloomberg NewsPharmaceutical companies including Pfizer Inc., Bristol-Myers Squibb Co. and Eli Lilly and Co. could be ready to start making
major acquisitions again.
MoreLilly's 2013 profit forecast tops expectations
January 4, 2013
Associated PressEli Lilly and Co. forecasts its 2013 earnings will grow more than Wall Street expects even though the drugmaker will lose
U.S. patent protection for two more key products in the new year.
MoreTrial set to begin over pregnancy drug sold by Lilly
January 3, 2013
Associated PressFour sisters diagnosed with breast cancer are suing Eli Lilly and Co., a former maker of DES, or diethylstilbestrol, a drug
taken by their mother in the 1950s when she was pregnant. It could be the first of scores of such trials over the drug.
MoreLilly agrees to pay $29.4M to settle SEC bribery charges
December 20, 2012
J.K. WallAccording to a statement released by the SEC, Eli Lilly paid $6.5 million—and in some cases gave jewelry and spa treatments—to
win government contracts in Brazil, China, Russia and Poland.
More
Sponsored by
ADVERTISEMENT
on Facebook & Twitter
on Facebook & Twitter
 Follow IBJ's Tweets on these topics: |
||
| @IBJNews | @Propertylines | @IBJTheScore |
| @IBJArts | @IBJHealthcare | @IBJDining |
| @IBJLists | @IBJSmallbiz | |
ADVERTISEMENT
Back to TopCopyright © All Rights Reserved. Privacy Policy | Terms of Use.
Design, CMS, Hosting & Web Development :: ePublishing.
Additional Hosting & Delivery by
Many serial killer types and psychopaths work as lowly bureaucrats, just waiting to impose their wrath on a powerless person, child, or pet. Don't forget, the BTK killer was a dog catcher.
If a television station wants to improve viewership, get rid of the local blackout. I was born by the brickyard, and have attended 15 or more races. I have children now, I won't attend unless circumstances are perfect. As those with growing families know, they never are. I'm always impressed that upwards of 250,000 people attend the 500. However, as a growing, or, more apt, sprawling city, Indianapolis and its immediate suburbs count almost 2.2 million. Show the race live, let the venue get a kick-back on revenues, and open-wheel racing might have a fighting chance to be relevant again. Just in time for those tax-payer lights to make sense.
John Moore, I too have had the same issue recently. A property next to my house was on the Land Bank and I was interested in purchasing. When I tried to contact Reggie, I got back emails that had nothing to do with what I asked about. Actually my latest response from him was on this past Friday. I had asked about how to buy the property and if it was still available. His response to me was to contact the mayor's office to get the schedule of his appearances. (???) Hopefully the city is able to do something to fix what this guy has done, it would be nice if they would take the properties back and sell them properly so land owners like me and you mother would have a fair chance.
I too work in the industry, with over 25 years of experience and your political spin has probably nothing to do with any rebranding. "Let's dress it up" would have nothing to do with the government "telling us how and what to eat." Give it a political rest. And being a producer for a radio show doesn't mean you've been involved in advertising and branding for 30 years.
Ms. Morris did not understand the ways of the business world, otherwise, like the IMS, she could have petitioned the State Legislature for a handout of State Funds for her charity work. Ms. Morris should consider becoming a state lobbyist for Lemonade Stand Operators.